| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83f04dab377e19b2102c9603151cad3d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K4-00 |
| filingDate |
2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89716e04960f8234225a6aece8d02640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f712874754393eff0e65b2cdbcd3f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f51ae16c514af52cedb56d05b6824ec |
| publicationDate |
2020-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202027786-A |
| titleOfInvention |
Immune inducer containing antigen peptide-adjuvant nucleotide conjugate and medical composition containing the same |
| abstract |
The present invention provides an immune inducer and a pharmaceutical composition containing the same. The immune inducer contains a polynucleotide/peptide conjugate as an effective ingredient, and the polynucleotide/peptide conjugate is a monomer containing a CpG motif. The chain polynucleotide or polynucleotide derivative and the antigenic peptide are bound via a spacer, which is covalently bound to the polynucleotide or polynucleotide derivative on one end and has an antigen on the other end. Sexual peptides are covalently bound. |
| priorityDate |
2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |